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Summary
Objective: Our aim was to investigate the maintenance of the transfection status of non-viral transfected chondrocytes in an alginate culture
system.
Design: Chondrocytes harvested from rabbit knees were isolated by sequential digestion and cultivated in monolayer culture. At 60–70% cell
density, chondrocytes were transfected with different transfection systems (FuGENE6, CaCl2, Lipofectin). A lacZ expression vector(pcDNA 3.1/Myc-His(+) lacZ) was used as a reporter system. In order to improve transfection rates, hyaluronidase (4 U/ml) was used prior
and during the transfection procedure. Thereafter, transfected cells were either kept in monolayer culture or embedded in alginate beads and
kept in culture for up to the next 30 weeks.
Results: Transfection efficiency was maximal using FuGENE6/DNA at a ratio of 3:2 and hyaluronidase (4 U/ml). Transfection efficiency
reached up to 40.8% (±3.2%) after 36 h. In alginate beads lacZ positive cells declined to 8.5%±3.3% after 4 weeks and to 4.6%±3.2% after
12 weeks of culturing. After 30 weeks 3% of chondrocytes still expressed lacZ. In contrast, during culturing in monolayer, no lacZ expression
was detectable after 4 weeks. Differentiation status of the chondrocytes was confirmed by histology and immunohistochemistry methods.
Conclusions: After successful gene transfer to rabbit chondrocytes the alginate system made it possible to culture lipofected chondrocytes
phenotypically stable. Genetically engineered chondrocytes express the lacZ reporter gene over a period of at least 30 weeks. This
transfection and culture system provides a promising tool to further investigate the over-expression of growth factors and enzyme inhibitors.
© 2002 OsteoArthritis Research Society International
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The spontaneous restoration of cartilage injuries reaching
to the subchondral bone leads to a regenerative tissue that
is biomechanically and biochemically inferior to hyaline
cartilage. Because of this insufficient repair process,
affected joints often develop painful and disabling degen-
erative joint disease.
Gene therapy might offer new perspectives in the treat-
ment of cartilage defects and osteoarthritis (OA). The
expression of ‘therapeutical’ proteins by genetically modi-
fied chondrocytes could overcome problems related to the
difficulty of administration of relevant doses of therapeutic
agents to the joint cavity and cartilage matrix1. Viral vectors
and non-viral gene delivery systems have been shown to
successfully engineer chondrocytes and synoviocytes2,3.
The expression of the gene encoding the soluble inter-
leukin 1 (IL-1)- receptor II protein leads to antiarthritic
effects in knee joints of rabbits4. Although viral vectors
effectively deliver nucleic acids to cells, this approach
has several disadvantages (i.e. the risk of replication of212competent virus or insertional mutagenesis in case of using
retroviruses) when compared to synthetic non-viral vec-
tors1. Furthermore it may be possible to repeat non-viral
gene transfer as this does not stimulate an immune
response like adenoviral vectors and there is no restriction
to the size of the transferable DNA in comparison to viral
vectors5.
In addition to the necessity of a safe and efficient gene
transfer especially in non-lethal chronic diseases like OA, a
sufficient duration of gene expression in the joint is
required. Up to now the time course of gene expression
after transfection has not been investigated in detail.
Therefore, the aim of our study was first to investigate
how effective non-viral vectors can deliver DNA to articular
rabbit chondrocytes. In addition we wanted to investigate
the time course of gene expression of a reporter system in
chondrocytes cultured in the three-dimensional alginate
culture system. The alginate system has been shown to
preserve the phenotype of chondrocytes over a long period
of time6.Material and methodsReceived 5 April 2001; revision requested 24 July 2001; revision
received 28 August 2001; accepted 15 October 2001.
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Cartilage from the medial and lateral condyle and tibia
plateau of 40 rabbit knees was harvested. Cartilage slices
were digested with 0.2% pronase (Sigma, Deisenhofen,
Germany) in DMEM (Biochrom seromed, Berlin, Germany)
for 30 min at 37°C, followed by a digestion in a 12 ml/g
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Mannheim, Mannheim, Germany) suspended in DMEM
with 10% fetal bovine serum (FBS) (Biochrom seromed,
Berlin, Germany) under gentle conditions at 37°C over 6 h
in a cell culture incubator. The released chondrocytes were
rinsed, filtered and counted. Viability was determined by
trypan blue staining and exceeded 90%. Approximately
1×106 chondrocytes were obtained from one knee.GENE TRANSFER TO CHONDROCYTES
The expression plasmid pCMV 3.1/Myc-His(+) lacZ was
obtained from Invitrogen (Groningen, The Netherlands). In
order to obtain the best transfection efficiency, transfections
were performed testing three different systems: FuGENE6
(Boehringer Mannheim, Mannheim, Germany), Lipofectin
(Invitrogen, Groningen, The Netherlands) or CaCl2 (Merck,
Darmstadt, Germany). In the case of FuGENE6, 100 l
transfection solution per 1 ml culture medium was used for
10 cm2. Transfection solution was prepared as follows
(example for concentration 3:2): incubation of 95 l DMEM
and 3 l FuGENE6 for 10 min, adding of 2 l DNA (1 g/l)
and incubation for further 10 min, adding this solution to the
culture medium, replacement of the culture medium the
following day. In case of Lipofectin 200 l transfection
solution per 1 ml serum free culture medium was used for
10 cm2. Transfection solution was prepared as follows:
solution A: 2 l DNA (1 g/l) was diluted in 98 l serum
free medium, solution B: Dilution of 4 l Lipofectin in 96 l
serum free medium and incubation of both at room tem-
perature for 45 min, combination of solution A and B and
incubation for 15 min at room temperature. After adding
0.8 ml serum free medium to the mixture of A and B, this
complex was given to the cells and incubated at 37°C in the
incubator. After 6 h serum free medium was replaced by
normal culture medium. For CaCl2 transfection standard
biochemistry techniques were used. Briefly, for one well
(10 cm2) we first mixed 1 g DNA with 100 l PBS
(pH 6.95), 25 l CaCl2 (stock solution 1 M) and 75 l H2O.
After 2 min we added this mixture dropwise to the culture
medium (1 ml). The culture well was incubated at 37°C and
3% CO2 for 8 h. Further incubation was performed at 37°C
and 5% CO2 after medium change. For optimization of
transfection efficiency only the most effective transfectionreagent (FuGENE6) was further tested. Therefore chon-
drocyte cultures were incubated with hyaluronidase
(Sigma, Deisenhofen, Germany) (stock solution 10 mg
hyaluronidase/ml aqua purum) at a concentration of 4 U/ml
culture medium. In order to analyse the effect of hyaluroni-
dase at different time points, hyaluronidase was added
either during or for pretreating chondrocyte cultures 6 h
before and during the transfection procedure at 37°C.
Negative controls consisted of cells treated with a transfec-
tion reagent lacking the reporter gene DNA.
Transfection efficiency was determined after 48 hours by
using a staining kit (X-gal; Promega, Mannheim, Germany).
Staining is performed using X-gal, whereby X-gal is the
substrate of the -galactosidase (LacZ) and turns to blue
after cleavage, so that transfected cells could be detected
after staining. Briefly, cells were fixed with 2% glutaralde-
hyde and 2% paraformaldehyde for 10 min and stained for
4 h at 37°C for -galactosidase activity. Efficiency (percent-
age of blue cells of all cells) was determined by counting
lacZ positive cells in five fields (1 mm2) from each plate
under the microscope (Zeiss, Oberkochen, Germany).ALGINATE CULTURE
To create alginate culture, transfected cells were isolated
by trypsinization and then suspended in 1.2% alginate
(Kelco, Chicago, U.S.A.) 36 h after the transfection pro-
cedure. By dropping the chondrocyte-alginate-suspension
with a 22 Gauge needle into an iso-osmotic
calciumchloride-solution (102 mM), alginate-beads con-
taining approximately 40,000 chondrocytes were formed6.
Alginate beads were kept in the same culture medium used
for monolayer for the next months. Culture medium was
changed twice weekly. Cultures of six independent carti-
lage preparations from different rabbit knees were cultured
over a period of 12 weeks. In regular intervals at least four
alginate beads were stained for X-gal and chondrocytes
were released from beads using dissolution buffer contain-
ing 55 mM sodium citrate, 30 mM EDTA and 0.15 M NaCl
(all Merck, Darmstadt, Germany).
Two alginate cultures from cartilage preparations of
different rabbit knees could be maintained over a period of
30 weeks. Each culture consisted of three wells. From each
well, the chondrocytes in beads were stained and chondro-
cytes were released in the 16th, the 22nd and the 30th
week as described above.
The percentage of transfected cells was calculated
by counting blue cells in a counting chamber (Brand,
Wertheim, Germany).HISTOLOGY AND IMMUNOHISTOCHEMISTRY
Alginate beads were fixed in 4% formalin Lillie containing
40 mmol CaCl2 overnight. Beads were then embedded in
paraffin and 5 m sections were prepared. In order to
analyse the chondrogenic status of the cells, sections were
stained with hematoxylin eosin (HE), safranin-O and colla-
gen II antibodies (DPC Biermann, Bad Nauheim, Germany)
using the streptavidin/biotin method (LSAB kit, Dako,
Hamburg, Germany). After an enzymatic digestion with
proteinase K (0.5 mg/ml in Tris pH 7.5; Boehringer
Mannheim, Mannheim, Germany) over 30 min at room
temperature the sections were incubated with the primary
antibody at a dilution of 1:400 overnight at 4°C. After
amplification with a biotinylated secondary antibody and
with streptavidin-HRP complex staining was visualized byCELL CULTURE
Isolated chondrocytes were placed in monolayer cul-
tures at a density of 6×105 cells per 25 cm2. Chondrocyte
cultures were incubated at 37°C, 95% humidity and 5%
CO2 and were fed every other day with basic medium.
Culture medium contained 45% Ham’s medium F12
(Biochrom seromed, Berlin, Germany), 45% DMEM, 10%
FBS, Ciprofloxacin (Bayer, Leverkusen, Germany) 50 g/
ml, ascorbic acid (Sigma, Deisenhofen, Germany) 10 g/ml
and glutamate (Biochrom seromed, Berlin, Germany)
0.2 mM.
Primary chondrocytes were grown to confluence and
after trypsinisation [0.05% Trypsin/0.02% EDTA in PBS w/o
Ca+ + and Mg+ + (all Biochrom seromed, Berlin, Germany)]
at 37°C for 10 min, chondrocytes were seeded in 24-well
plates, T25 or T75 flasks (Nunc, Wiesbaden, Germany) at a
density of 30,000 cells/cm2. After 24 h viable cells were
attached to culture plates and transfection experiments
were carried out at 60–70% cell density.
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Germany).ResultsMONOLAYER CULTURES
We obtained about 1×106 chondrocytes from each
rabbit knee. After seeding cells in monolayer culture they
adopted a fibroblast-like phenotype after 3–5 days.
Chondrocytes were grown to confluency during the next
3–4 weeks.
Through transfection of rabbit chondrocytes with differ-
ent systems and optimization for all tested systems a
successful gene transfer of lacZ could be demonstrated.
However, the transfection efficiency varied considerably.
Using CaCl2, the transfection efficiency reached 3%±0.9%.
A comparable efficiency could be reached using Lipofectin
(4.2%±1.2%). The highest transfection efficiency was
obtained with the lipid formulation FuGENE6 (21%±1.3%).
Gene transfer with FuGENE6 showed an increase of effi-
ciency by using the system at a ratio of lipid formulation/
DNA of 3:2 (Fig. 1). Further optimization of gene transfer
was achieved when chondrocytes were treated 6 h before
and during transfection with hyaluronidase at a concen-tration of 4 U/ml (Fig. 1). Treatment with hyaluronidase
increased efficiency by almost 100% to 40.8%±3.2%.LONG-TERM EXPRESSION OF REPORTER GENECultivation in monolayer
After transfection with FuGENE6, gene expression of the
reporter gene in monolayer cultured chondrocytes reached
3.5%±1.8% after 2 weeks. No lacZ expression could be
detected after 4 weeks in monolayer culture.Cultivation in alginate beads
In alginate beads chondrocytes adopted their spherical
morphology and after X-gal staining positive lacZ positive
cells turned blue. Negative controls failed to reveal lacZ
positive cells.
The time course of percentage of chondrocyte with lacZ
expression following transfection with FuGENE6 is shown
in Fig. 2 for the first 12 weeks. One week after seeding the
chondrocytes in alginate beads, the percentage of reporter
gene positive cells was 12.7%±3.5%. The lacZ expression
declined over the following weeks as follows: 8.5%±3.3%
after 4 weeks, 5.1%±2.03% after 8 weeks and 4.6%±3.2%
after 12 weeks. Percentage of positive chondrocytes
declined more slowly over the next 18 weeks to
2.8%±1.3% (16 w: 3.5%±1.1%; 22 w: 3.1%±2%).0
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Fig. 1. Transfection efficiencies of different non-viral systems in
rabbit chondrocytes cultivated in monolayer. Optimal transfection
was reached at ratio of FuGENE6 to DNA at 3:2 and a mild
digestion of pericellular matrix with hyaluronidase at 4 U/ml.0 12
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Fig. 2. Time course of lacZ expression in rabbit chondrocytes
transfected with FuGENE6 (N=6). Chondrocytes are cultured in
alginate beads. At the listed time points beads were stained with
X-gal and chondrocytes were released from beads to calculate the
ratio of lacZ positive and negative cells. After 30 weeks the
percentage of lacZ positive chondrocytes declined to 2.8%±1.3%.
Cultures: 1, ; 2, ; 3, ; 4, ×; 5, ; 6, .Fig. 3. Histology of transfected articular chondrocytes cultured in alginate beads after gene transfer of lacZ (transfection with FuGENE6).
Chondrocytes were transfected in monolayer culture and then embedded in alginate beads for further cultivation of 30 weeks. Cells are
stained with X-gal to analyse transfection status (lacZ positive chondrocytes are marked by arrows): (a) 4 weeks after gene transfer
(magnification×100); (b) 4 months after gene transfer with a decline of lacZ positive chondrocytes in comparison to (a) (magnification×200);
(c) safranin-O staining of 12 weeks old alginate beads (magnification×400) showing the accumulation of glycosaminoglycans in the matrix;
(d) collagen type II antibody staining (magnification×400) showing the expression of collagen type II.HISTOLOGY
The chondrocyte phenotype of the cells was proofed by
different methods [Fig. 3(c) and (d)]. Paraffin sections ofSTATISTICAL ANALYSIS
Results are expressed as mean and standard deviation.
Experiments testing different transfection systems were
repeated at least three times. Experiments to optimize
transfection with FuGENE6 and hyaluronidase were
repeated eight times. Transfection efficiency of chondro-
cytes cultured in alginate beads was measured at least in
triplicate. Student’s t-test was used for statistical analysis
(level of significance P<0.05).
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chondrocytes. Proteoglycan production and accumulation
in the surrounding matrix was detected histologically by
safranin-O staining. Furthermore, immunohistochemistry
confirmed phenotypically stable chondrocytes by showing
collagen type II expression. In the pericellular matrix
of more than 90% of the cells (transfected and non-
transfected) we found collagen type II expression.Discussion
The stimulation of anabolism in cartilage tissue by differ-
ent growth factors such as bone morphogenetic protein,
transforming growth factor, or IGF, might facilitate restor-
ation of cartilage in OA and cartilage injuries7,8. However,
the half-life and the difficulties in applying those agents to
the joint have limited its potential application8. Delivering
genes to chondrocytes in vitro and reimplantation to
affected joints could circumvent the necessity for repeated
injections or systemic application. The success of local
gene therapy, however, is among other things tied to the
efficiency of transfection and duration of expression time of
the transferred gene.
Up to now mainly viral vectors have been used to deliver
genes to chondrocytes of various origins9–11. The transfec-
tion efficiency using retroviral, adenoviral or adeno associ-
ated virus reached up to 100% (see Oligino et al. for
review)1,9,11,12. So far, only a few studies report the suc-
cessful genetically modification of chondrocytes by a non-
viral system3,13,14. But it is unclear how long chondrocytes
can maintain the additional DNA and how long expression
is maintained.
In this study, we show that chondrocytes of rabbit knee
joints can be effectively genetically engineered using a
non-viral system. Madry and Triple have demonstrated
that with the lipid preparation FuGENE6 it is possible also
to transfect bovine chondrocytes and human chondrocytes
at a transfection efficiency of 7.6% to 9.0%3. Transfection
efficiency of gene delivery systems varies between different
cell types and techniques improving the access to the
cells. We could demonstrate increasing transfection effi-
ciency by using hyaluronidase before and during gene
delivery procedure. Transfection efficiency reached 41% for
the FuGENE6 lipid preparation in optimized transfection
conditions. These results are also in agreement with pre-
vious studies enhancing transfection efficiency of bovine
cultures with hyaluronidase3. In our study the optimal ratio
of lipid to DNA was found to be 3:2. In bovine chondrocyte
cultures the optimal ratio was 3:13. Only by using more
complex non-viral systems with a ligand complex is it
possible to improve the transfection efficiency in rabbit
chondrocytes by a factor of 1.6 in comparison to our
results13.
The treatment of chronic diseases like OA requires a
long-term expression of genes encoding a therapeutic
protein. However, most studies showed a limited expres-
sion time of viral vectors for up to 8 weeks in chondrocytes
and for non-viral systems of 2 weeks3,9,11. We demonstrate
a gene expression of lacZ over several months in chondro-
cytes cultured in alginate beads. This result is in sharp
contrast to the time course of lacZ expression in monolayer
culture. The result demonstrates the feasibility of the main-
tenance of non-viral genetically engineered chondrocytes
in the three-dimensional matrix alginate. As expected, the
percentage of lacZ positive chondrocytes declined over the
observation period but we still found 3% positive cells after8 months. Although the proliferation of chondrocytes in
alginate beads is very low, the inability of the foreign DNA
to replicate might be one reason for the decline of trans-
fected cells. In contrast to the alginate system, in mono-
layer cultures the proliferation rate is high and therefore no
lacZ expression in chondrocytes could be detected after
4 weeks.
One potential application of genetically modified
chondrocytes is the filling of chondral defects. This would
require a multiplication of chondrocytes. Before transfec-
tion of chondrocytes we let cells proliferate in primary
monolayer culture. After transfection cells adopted their
spherical morphology in alginate beads. The applied algi-
nate matrix has been shown to keep chondrocytes in their
typical spherical phenotype and chondrocytes express typi-
cal metabolites like aggrecan and collagen type II6. We
confirm a stable chondrogenic phenotype of the cells
through histological and immunohistochemical analysis of
the alginate beads. Our results demonstrate that both
transfected and not transfected chondrocytes produce pro-
teoglycans and collagen type II. This is worth noting as
transfection might have cytotoxic effects or the expression
of the reporter gene might interfere with the protein expres-
sion of the regular chondrogenic matrix15.
Beside viral transfection systems non–viral systems offer
the opportunity of an effective gene transfer and a possible
gene expression over several months. Especially for safety
reasons this non-viral system could open further perspec-
tives for non-life-threatening diseases like OA and chondral
defects.Acknowledgments
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